The Goldman Sachs Group, Inc. 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-07 4:33 pm Sale | 2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI | GOLDMAN SACHS GROUP INC GS | 396,136 0.900% | -1,701,511 (-81.12%) | Filing |
| 2022-02-08 4:43 pm Purchase | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | GOLDMAN SACHS GROUP INC GS | 2,097,647 5.100% | 2,097,647 (New Position) | Filing |